Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Pharmaceutics

• Publication date

  2013-10-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp400439qPMID 24066837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maintenance of supersaturation II: indomethacin crystal growth kinetics versus degree of supersaturation.

  2013cited by this paper
• Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.

  2012cited by this paper
• Supersaturating drug delivery systems: fast is not necessarily good enough.

  2012cited by this paper
• Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.

  2012cited by this paper
• Recent developments in understanding of the metastable zone width of different solute―solvent systems

  2011cited by this paper
• Effects of the rate of supersaturation generation on polymorphic crystallization of m-hydroxybenzoic acid and o-aminobenzoic acid

  2011cited by this paper
• Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions: Implications for In-Situ Concentration Monitoring Using UV/Vis Fiber-Optic Probes

  2011cited by this paper
• Dissolution and precipitation behavior of amorphous solid dispersions.

  2011cited by this paper
• Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?

  2011cited by this paper
• Supersaturation rates and schedules: Nucleation kinetics from isothermal metastable zone widths

  2011cited by this paper
• Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.

  2011cited by this paper
• Crystal forms of naproxen

  2011cited by this paper
• Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement

  2011cited by this paper
• Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility

  2010cited by this paper
• Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution

  2010cited by this paper
• Dependence of the critical undercooling for crystallization on the cooling rate.

  2010cited by this paper
• Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.

  2010cited by this paper
• Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.

  2010cited by this paper
• Solubility Advantage of Amorphous Pharmaceuticals: II. Application of Quantitative Thermodynamic Relationships for Prediction of Solubility Enhancement in Structurally Diverse Insoluble Pharmaceuticals

  2010cited by this paper
• Indomethacin polymorphs: Experimental and conformational analysis.

  2009cited by this paper
• Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu

  2009cited by this paper
• Current status of amorphous formulation and other special dosage forms as formulations for early clinical phases.

  2009cited by this paper
• Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.

  2008cited by this paper
• Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.

  2008cited by this paper
• Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties.

  2008cited by this paper
• Nucleation and crystal growth in supersaturated solutions of a model drug.

  2008cited by this paper
• Drug delivery strategies for poorly water-soluble drugs

  2007cited by this paper
• Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.

  2007cited by this paper
• Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.

  2007cited by this paper
• Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.

  2007cited by this paper
• A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems

  2006cited by this paper
• Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

  2006cited by this paper
• Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion.

  2005cited by this paper
• The use of three different solid dispersion formulations--melt extrusion, film-coated beads, and a glass thermoplastic system--to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor.

  2004cited by this paper
• Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations.

  2004cited by this paper
• Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers.

  2004cited by this paper
• Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.

  2003cited by this paper
• Characterization of piroxicam crystal modifications.

  2003cited by this paper
• The mechanisms of drug release from solid dispersions in water-soluble polymers.

  2002cited by this paper
• Modeling the Gas Antisolvent Recrystallization Process

  2002cited by this paper
• Morphological evaluation of the γ-polymorph of indomethacin

  2002cited by this paper
• Estimation of metastable zone width in different nucleation processes

  2001cited by this paper
• Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry.

  2001cited by this paper
• Amorphous pharmaceutical solids: preparation, characterization and stabilization.

  2001cited by this paper
• Improving drug solubility for oral delivery using solid dispersions.

  2000cited by this paper
• What is the True Solubility Advantage for Amorphous Pharmaceuticals?

  2000cited by this paper
• A new model of periodic precipitation incorporating nucleation, growth and ripening

  1999cited by this paper
• Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

  1999cited by this paper
• Improving the Oral Bioavailability of Albendazole in Rabbits by the Solid Dispersion Technique

  1999cited by this paper
• Characteristics and significance of the amorphous state in pharmaceutical systems.

  1997cited by this paper
• Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.

  1994cited by this paper
• Model identification and control of solution crystallization processes: a review

  1993cited by this paper
• Precipitation: Basic Principles and Industrial Applications

  1992cited by this paper
• The rate and mechanism of polymorphic transformation of calcium carbonate in water

  1990cited by this paper
• Kinetics of the intermediate stage of phase transition in batch crystallization

  1990cited by this paper
• Indomethacin delivery from matrix controlled release indomethacin tablets

  1989cited by this paper
• Measurements and a hypothesis on periodic precipitation processes

  1987cited by this paper
• Vapour pressure, solubility and affinity of undercooled melts and glasses

  1986cited by this paper
• Patterns produced by precipitation at a moving reaction front.

  1986cited by this paper
• Patterns produced by precipitation at a moving reaction front

  1986cited by this paper
• FORMATION OF SILVER BROMIDE CRYSTALS IN DOUBLE-JET PRECIPITATION.

  1980cited by this paper
• Wettability of pharmaceutical solids: estimates of solid surface polarity.

  1976cited by this paper
• Modeling crystal growth rates from solution

  1973cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper
• Nucleation at time-dependent supersaturation

  1970cited by this paper
• Thermodynamic Driving Force in Nucleation and Growth Processes

  1958cited by this paper
• Theory, Production and Mechanism of Formation of Monodispersed Hydrosols

  1950cited by this paper
• On the Thermodynamic Relation between Surface Tension and Curvature

  1950cited by this paper

• Approaching drug release performance from mesoporous silica formulations by modeling of chemical potentials.

  2025cites this paper
• Enhanced oral bioavailability of paclitaxel amorphous solid dispersions by maximizing supersaturation

  2025cites this paper
• Enhancing solubility, bioavailability and anti-cancer efficacy of aprepitant through a naringin-based co-amorphous system

  2025cites this paper
• AI-Enhanced X-ray Microscopy for Non-Destructive Detection, Quantification, and Particle Size Analysis of Crystalline Miconazole in Amorphous Solid Dispersions.

  2025cites this paper
• Artificial gut Simulator. A scheme to predict intestinal and plasma concentration-time profiles of a weakly basic BCS-II drug, dipyridamole.

  2025cites this paper
• Targeting anti-apoptotic mechanisms in tumour cells: Strategies for enhancing Cancer therapy.

  2025cites this paper
• Exploring mesoporous silica microparticles in pharmaceutical sciences: Drug delivery and therapeutic insights.

  2025cites this paper
• Theory for the structural relaxation and self-diffusion of amorphous indomethacin under various thermodynamic conditions.

  2025cites this paper
• Supramolecular synthonic portions in heat-treated indomethacin-carbamazepine mixture: a singular value decomposition approach for Fourier-Transform infrared spectral analysis.

  2025cites this paper
• In vivo performance of amorphous solid dispersions based on water-insoluble versus water-soluble carriers: Fenofibrate case study.

  2025cites this paper
• Mechanistic Insights into Amorphous Solid Dispersions: Bridging Theory and Practice in Drug Delivery

  2025cites this paper
• DSPindex guides dose selection to extend drug supersaturation lifetime during cocrystal dissolution.

  2025cites this paper
• Neat Amorphous Form and Amorphous Solid Dispersions of Apalutamide: A Comparative Study

  2025cites this paper
• Physical mixing of water-soluble polymers with amorphous solid dispersions based on L-HPC: supporting supersaturation and improving the kinetic solubility profile

  2025cites this paper
• New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability

  2024cites this paper
• Investigation of the Influence of Anti-Solvent Precipitation Parameters on the Physical Stability of Amorphous Solids

  2024cites this paper
• Characterization and Dissolution Mechanism of Low-Molecular-Weight Organic Acids or Inorganic Mesoporous Particle-Based Piperine Amorphous Solid Dispersions.

  2024cites this paper
• Optimizing Nonsink Dissolution Testing for Amorphous Solid Dispersions: Exploring Sample Handling Variables.

  2024cites this paper
• An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis

  2024cites this paper
• An Artificial Gut/Absorption Simulator: Understanding the Impact of Absorption on In Vitro Dissolution, Speciation, and Precipitation of Amorphous Solid Dispersions.

  2024cites this paper
• Amorphous Solubility Advantage: Theoretical Considerations, Experimental Methods, and Contemporary Relevance.

  2024cites this paper
• Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design

  2023cites this paper
• Orthogonal Analytical Methods to Elucidate How Low Levels of Residual Crystallinity in Posaconazole Amorphous Solid Dispersions Impact Phase Behavior during Release

  2023cites this paper
• Impact of Processing Methods on the Physico-chemical Properties of Posaconazole Amorphous Solid Dispersions

  2023cites this paper
• Fused Deposition Modelling 3D printing and solubility improvement of BCS II and IV active ingredients - A narrative review.

  2023cites this paper
• The inherent AIE feature revealed the drug molecular state in cyclodextrin metal–organic framework for enhanced stability and absorption

  2023cites this paper
• Design, Development and in vitro quantification of novel electrosprayed Everolimus-loaded Soluplus®/Polyvinyl alcohol nanoparticles via stability-indicating HPLC method in cancer therapy.

  2023cites this paper
• Effect of Structurally Related Compounds on Desupersaturation Kinetics of Indomethacin

  2023cites this paper
• Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer

  2023cites this paper
• Amorphous solid dispersions in high-swelling, low-substituted hydroxypropyl cellulose for enhancing the delivery of poorly soluble drugs.

  2023cites this paper
• Assessing the performance of thermally crosslinked amorphous solid dispersions with high drug loadings.

  2023cites this paper
• Study on the Role of Polymers in Preventing the Crystallization of Roxadustat in an Aqueous Environment

  2023cites this paper
• Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole.

  2023cites this paper
• Superiority of Mesoporous Silica-Based Amorphous Formulations over Spray-Dried Solid Dispersions

  2022cites this paper
• Simultaneous recovery of Cu2O and FeOOH from wastewater contaminated with mixed metals using fluidized-bed crystallization

  2022cites this paper
• The drug loading impact on dissolution and diffusion: a case-study with amorphous solid dispersions of nevirapine

  2022cites this paper
• Emerging Artificial Intelligence (AI) Technologies Used in the Development of Solid Dosage Forms

  2022cites this paper
• Characterization of nimodipine amorphous nanopowder prepared by quenching cooling combined with wet milling and spray drying.

  2022cites this paper
• Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization

  2022cites this paper
• Enteric Polymer–Based Amorphous Solid Dispersions Enhance Oral Absorption of the Weakly Basic Drug Nintedanib via Stabilization of Supersaturation

  2022cites this paper
• Design and molecular insights of drug-active metabolite based co-amorphous formulation: a case study of toltrazuril-ponazuril co-amorphous.

  2022cites this paper
• Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling.

  2022cites this paper
• A critical review on thermodynamic and hydrodynamic modeling and simulation of liquid antisolvent crystallization of pharmaceutical compounds

  2022cites this paper
• Incorporation of itraconazole nano-co-crystals into multiparticulate oral dosage forms.

  2022cites this paper
• Semicrystalline Polymer Micro/Nanostructures Formed by Droplet Evaporation of Aqueous Poly(ethylene oxide) Solutions: Effect of Solution Concentration

  2022cites this paper
• Hot-melt extruded hydroxypropyl methylcellulose acetate succinate based amorphous solid dispersions: Impact of polymeric combinations on supersaturation kinetics and dissolution performance.

  2022cites this paper
• Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug–Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug

  2022cites this paper
• Boost of solubility and supersaturation of celecoxib via synergistic interactions of methacrylic acid-ethyl acrylate copolymer (1:1) and hydroxypropyl cellulose in ternary amorphous solid dispersions

  2022cites this paper
• Polyelectrolyte Matrices in the Modulation of Intermolecular Electrostatic Interactions for Amorphous Solid Dispersions: A Comprehensive Review

  2021cites this paper
• Handbook of Pyrrolidone and Caprolactam Based Materials: Synthesis, Characterization and Industrial Applications, 6 Volume Set: Cocrystals, Coamorphous Phases and Coordination Complexes of Î3â•’ and <fc>Îμâ•’Lactams</fc>

  2021cites this paper
• Characterization of excipients to improve pharmaceutical properties of sirolimus in the supercritical anti-solvent fluidized process.

  2021cites this paper
• Blended polymeric films containing the drugs simvastatin and resveratrol: The supersaturation approach for melanoma treatment

  2021cites this paper
• Tailoring Release Profiles of BCS Class II Drugs Using Controlled Release Amorphous Solid Dispersion Beads with Membrane-Reservoir Design: Effect of Pore Former and Coating Levels.

  2021cites this paper
• Crystal Growth Kinetics of an Industrial Active Pharmaceutical Ingredient: Implications of Different Representations of Supersaturation and Simultaneous Growth Mechanisms

  2021cites this paper
• Role of Permeability on the Biopredictive Dissolution of Amorphous Solid Dispersions

  2021cites this paper
• Supersaturation and Solubilization upon In Vitro Digestion of Fenofibrate Type I Lipid Formulations: Effect of Droplet Size, Surfactant Concentration and Lipid Type

  2021cites this paper
• Stabilization of the Metastable α-Form of Indomethacin Induced by the Addition of 2-Hydroxypropyl-β-Cyclodextrin, Causing Supersaturation (Spring) and Its Sustaining Deployment (Parachute).

  2021cites this paper
• Cocrystals, Coamorphous Phases and Coordination Complexes of γ‐ and ε‐Lactams

  2021cites this paper
• On the usefulness of sink index in characterizing the degree of nonsinkness in dissolution studies.

  2021cites this paper
• Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.

  2021cites this paper
• Indomethacin Co-amorphous Drug-Drug Systems with Improved Solubility, Supersaturation, Dissolution Rate and Physical Stability.

  2021cites this paper
• Electrospun fixed dose combination fibers for the treatment of cardiovascular disease.

  2021cites this paper
• A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions

  2021cites this paper
• A promising approach to design thermosensitive in situ gel based on solid dispersions of desloratadine with Kolliphor® 188 and Pluronic® F127

  2021cites this paper
• Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole

  2021cites this paper
• Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.

  2020cites this paper
• Correlation between drug dissolution and resistance to water-induced phase separation in solid dispersion formulations revealed by solid-state NMR spectroscopy.

  2020cites this paper
• Dissolution Enhancement of Carbamazepine using Twin-screw Melt Granulation.

  2020cites this paper
• A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.

  2020cites this paper
• Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions

  2020cites this paper
• The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.

  2020cites this paper
• Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.

  2020cites this paper
• Applications of Dynamic Mechanical Analysis in the Engineering of Amorphous Solid Dispersions

  2020cites this paper
• Evolution of Supersaturation from Amorphous Solid Dispersions in Water-Insoluble Polymer Carriers: Effects of Swelling Capacity and Interplay between Partition and Diffusion.

  2020cites this paper
• Recovery of amorphous drug-polyelectrolyte nanoparticle complex by salt-induced flocculation to circumvent the need for ultracentrifugation

  2020cites this paper
• Bioavailability Improvement of Carbamazepine via Oral Administration of Modified-Release Amorphous Solid Dispersions in Rats

  2020cites this paper
• Novel analytical approaches for solid dispersion characterization

  2020cites this paper
• Characterizing Drug-Polymer Interactions in Aqueous Solution with Analytical Ultracentrifugation.

  2020cites this paper
• An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design.

  2020cites this paper
• Biopredictive in vitro testing methods to assess intestinal drug absorption from supersaturating dosage forms

  2020cites this paper
• Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer.

  2020cites this paper
• One-step preparation of sustained-release ASDs using mesoporous spherical silica

  2020cites this paper
• The Opposed Effects of Polyvinylpyrrolidone K30 on Dissolution and Precipitation for Indomethacin Supersaturating Drug Delivery Systems

  2020cites this paper
• 3D-Printed Solid Dispersion Drug Products

  2019cites this paper
• Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.

  2019cites this paper
• Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder.

  2019cites this paper
• Physical Stability of an Amorphous Sugar Matrix Dried From Methanol as an Amorphous Solid Dispersion Carrier and the Influence of Heat Treatment.

  2019cites this paper
• Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility

  2019cites this paper
• Amorphous nanoparticles by self-assembly: processing for controlled release of hydrophobic molecules.

  2019cites this paper
• Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer

  2019cites this paper
• The Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent Methods

  2019cites this paper
• Preparation of cocrystal-in-excipient systems by advanced pharmaceutical methods

  2019cites this paper
• Assessing the impact of endogenously derived crystalline drug on the in vivo performance of amorphous formulations.

  2019cites this paper
• Nuances in the Calculation of Amorphous Solubility Enhancement Ratio.

  2019cites this paper
• Insights on role of polymers in precipitation of celecoxib from supersaturated solutions as assessed by focused beam reflectance measurement (FBRM).

  2019cites this paper
• Biphasic drug release testing coupled with diffusing wave spectroscopy for mechanistic understanding of solid dispersion performance.

  2019cites this paper
• Cocrystal solubility advantage diagrams as a means to control dissolution, drug supersaturation and precipitation.

  2019cites this paper
• Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations

  2019cites this paper
• Multi-scale analysis of amorphous solid dispersions prepared by freeze drying of ibuprofen loaded acrylic polymer nanoparticles

  2019cites this paper
• Enhanced Drug Delivery by Dissolution of Amorphous Drug Encapsulated in a Water Unstable MOF.

  2019cites this paper